Zachary M Sellers1, Donna MacIsaac2, Helen Yu3, Melody Dehghan3, Ke-You Zhang4, Rachel Bensen3, Jessie J Wong5, Cindy Kin6, K T Park3. 1. Pediatric Gastroenterology, Hepatology, and Nutrition, Stanford University, Palo Alto, California. Electronic address: zsellers@stanford.edu. 2. Pediatric Gastroenterology, Hepatology, and Nutrition, Stanford University, Palo Alto, California; Surgery, Stanford University, Palo Alto, California. 3. Pediatric Gastroenterology, Hepatology, and Nutrition, Stanford University, Palo Alto, California. 4. Pediatrics, Stanford University, Palo Alto, California. 5. Veterans Affairs Palo Alto Healthcare System, Palo Alto, California; Center for Primary Care and Outcomes Research, Stanford University, Palo Alto, California. 6. Surgery, Stanford University, Palo Alto, California.
Abstract
BACKGROUND & AIMS: Epidemiologic analyses of acute pancreatitis (AP) and chronic pancreatitis (CP) provide insight into causes and strategies for prevention and affect allocation of resources to its study and treatment. We sought to determine current and accurate incidences of AP and CP, along with the prevalence of CP, in children and adults in the United States. METHODS: We collected data from the Truven MarketScan Research Databases of commercial inpatient and outpatient insurance claims in the United States from 2007 through 2014 (patients 0-64 years old). We calculated the incidences of AP and CP and prevalence of CP based on International Classification of Diseases, 9th Revision diagnosis codes. Children were defined as 18 years or younger and adults as 19 to 64 years old. RESULTS: The incidence of pediatric AP was stable from 2007 through 2014, remaining at 12.3/100,000 persons in 2014. Meanwhile, the incidence for adult AP decreased from 123.7/100,000 persons in 2007 to 111.2/100,000 persons in 2014. The incidence of CP decreased over time in children (2.2/100,000 persons in 2007 to 1.9/100,000 persons in 2014) and adults (31.7/100,000 persons in 2007 to 24.7/100,000 persons in 2014). The prevalences of pediatric and adult CP were 5.8/100,000 persons and 91.9/100,000 persons, respectively, in 2014. Incidences of AP and CP increased with age. We found little change in incidence during the first decade of life but linear increases starting in the second decade. CONCLUSIONS: We performed a comprehensive epidemiologic analysis of privately insured, non-elderly adults and children with AP and CP in the United States. Changes in gallstone formation, smoking, and alcohol consumption, along with advances in pancreatitis management, may be responsible for the stabilization and even decrease in the incidences of AP and CP.
BACKGROUND & AIMS: Epidemiologic analyses of acute pancreatitis (AP) and chronic pancreatitis (CP) provide insight into causes and strategies for prevention and affect allocation of resources to its study and treatment. We sought to determine current and accurate incidences of AP and CP, along with the prevalence of CP, in children and adults in the United States. METHODS: We collected data from the Truven MarketScan Research Databases of commercial inpatient and outpatient insurance claims in the United States from 2007 through 2014 (patients 0-64 years old). We calculated the incidences of AP and CP and prevalence of CP based on International Classification of Diseases, 9th Revision diagnosis codes. Children were defined as 18 years or younger and adults as 19 to 64 years old. RESULTS: The incidence of pediatric AP was stable from 2007 through 2014, remaining at 12.3/100,000 persons in 2014. Meanwhile, the incidence for adult AP decreased from 123.7/100,000 persons in 2007 to 111.2/100,000 persons in 2014. The incidence of CP decreased over time in children (2.2/100,000 persons in 2007 to 1.9/100,000 persons in 2014) and adults (31.7/100,000 persons in 2007 to 24.7/100,000 persons in 2014). The prevalences of pediatric and adult CP were 5.8/100,000 persons and 91.9/100,000 persons, respectively, in 2014. Incidences of AP and CP increased with age. We found little change in incidence during the first decade of life but linear increases starting in the second decade. CONCLUSIONS: We performed a comprehensive epidemiologic analysis of privately insured, non-elderly adults and children with AP and CP in the United States. Changes in gallstone formation, smoking, and alcohol consumption, along with advances in pancreatitis management, may be responsible for the stabilization and even decrease in the incidences of AP and CP.
Authors: Stephen E Roberts; Sian Morrison-Rees; Ann John; John G Williams; Tim H Brown; David G Samuel Journal: Pancreatology Date: 2017-01-19 Impact factor: 3.996
Authors: David C Whitcomb; Luca Frulloni; Pramod Garg; Julia B Greer; Alexander Schneider; Dhiraj Yadav; Tooru Shimosegawa Journal: Pancreatology Date: 2016-02-16 Impact factor: 3.996
Authors: Jorge D Machicado; Stephen T Amann; Michelle A Anderson; Judah Abberbock; Stuart Sherman; Darwin L Conwell; Gregory A Cote; Vikesh K Singh; Michele D Lewis; Samer Alkaade; Bimaljit S Sandhu; Nalini M Guda; Thiruvengadam Muniraj; Gong Tang; John Baillie; Randall E Brand; Timothy B Gardner; Andres Gelrud; Christopher E Forsmark; Peter A Banks; Adam Slivka; C Mel Wilcox; David C Whitcomb; Dhiraj Yadav Journal: Am J Gastroenterol Date: 2017-02-28 Impact factor: 10.864
Authors: Alex Mirnezami; Ben Knight; Brendan Moran; Fergus Noble; Graham Branagan; John Primrose; Katherine Pearson; Malcolm West; Nathan Curtis; Phil Pucher; Ramsey Cuttress; Sian Pugh; Tim Underwood Journal: Ann R Coll Surg Engl Date: 2019-07-30 Impact factor: 1.891
Authors: Aliye Uc; Emily R Perito; John F Pohl; Uzma Shah; Maisam Abu-El-Haija; Bradley Barth; Melena D Bellin; Kate M Ellery; Douglas S Fishman; Cheryl E Gariepy; Matthew J Giefer; Tanja Gonska; Melvin B Heyman; Ryan W Himes; Sohail Z Husain; Asim Maqbool; Maria R Mascarenhas; Brian A McFerron; Veronique D Morinville; Tom K Lin; Quin Y Liu; Jaimie D Nathan; Sue J Rhee; Chee Y Ooi; Zachary M Sellers; Sarah Jane Schwarzenberg; Jose Serrano; David M Troendle; Steven L Werlin; Michael Wilschanski; Yuhua Zheng; Ying Yuan; Mark E Lowe Journal: Pancreas Date: 2018 Nov/Dec Impact factor: 3.327
Authors: Maisam Abu-El-Haija; Anna S Gukovskaya; Dana K Andersen; Timothy B Gardner; Peter Hegyi; Stephen J Pandol; Georgios I Papachristou; Ashok K Saluja; Vikesh K Singh; Aliye Uc; Bechien U Wu Journal: Pancreas Date: 2018 Nov/Dec Impact factor: 3.327
Authors: Dhiraj Yadav; Walter G Park; Evan L Fogel; Liang Li; Suresh T Chari; Ziding Feng; William E Fisher; Christopher E Forsmark; Christie Y Jeon; Aida Habtezion; Phil A Hart; Steven J Hughes; Mohamed O Othman; Jo Ann S Rinaudo; Stephen J Pandol; Temel Tirkes; Jose Serrano; Sudhir Srivastava; Stephen K Van Den Eeden; David C Whitcomb; Mark Topazian; Darwin L Conwell Journal: Pancreas Date: 2018 Nov/Dec Impact factor: 3.327
Authors: Maisam Abu-El-Haija; Lindsey Hornung; Tom K Lin; Jaimie D Nathan; Tyler Thompson; David S Vitale; Alexander Nasr; Sohail Z Husain; Lee Denson Journal: Pancreatology Date: 2020-07-24 Impact factor: 3.996
Authors: Walter G Park; Liang Li; Savitri Appana; Wei Wei; Kimberly Stello; Dana K Andersen; Steven J Hughes; David C Whitcomb; Randall E Brand; Dhiraj Yadav; Aida Habtezion Journal: Pancreatology Date: 2019-11-25 Impact factor: 3.996